Self-assembly into virus–like particles of the recombinant capsid protein of porcine circovirus type 3 and its application on antibodies detection

Development and application of a baculovirus-expressed capsid protein-based indirect ELISA for detection of porcine circovirus 3 IgG antibodies

(2019) Sujiao Zhang et al.   BMC Veterinary Research

Comparison of the size distributions and immunogenicity of human papillomavirus type 16 L1 virus-like particles produced in insect and yeast cells

(2018) Hyoung Jin Kim et al.   ARCHIVES OF PHARMACAL RESEARCH

Retrospective study of porcine circovirus 3 infection in China

(2018) J. Sun et al.   Transboundary and Emerging Diseases

Full-genome sequencing of porcine circovirus 3 field strains from Denmark, Italy and Spain demonstrates a high within-Europe genetic heterogeneity

(2018) G. Franzo et al.   Transboundary and Emerging Diseases

First report of wild boar susceptibility to Porcine circovirus type 3: High prevalence in the Colli Euganei Regional Park (Italy) in the absence of clinical signs

(2018) Giovanni Franzo et al.   Transboundary and Emerging Diseases

A Duplex Real-Time PCR Assay for the Simultaneous Detection of Porcine Circovirus 2 and Circovirus 3

(2018) Xiangdong Li et al.   VIROLOGICA SINICA

The prevalence and genetic characteristics of porcine circovirus type 2 and 3 in Korea

(2018) Seung-Chai Kim et al.   BMC Veterinary Research

Porcine circovirus 3 is highly prevalent in serum and tissues and may persistently infect wild boar (Sus scrofa scrofa )

(2018) Francini Klaumann et al.   Transboundary and Emerging Diseases

A novel NADC30-like porcine reproductive and respiratory syndrome virus (PRRSV) plays a limited role in the pathogenicity of porcine circoviruses (PCV2 and PCV3) and PRRSV co-infection

(2018) Nanhua Chen et al.   Transboundary and Emerging Diseases

Comprehensive evaluation of differential serodiagnosis between Zika and dengue viral infection

(2018) Day-Yu Chao et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Induction of porcine dermatitis and nephropathy syndrome in piglets by infection with porcine circovirus type 3

(2018) Haijun Jiang et al.   JOURNAL OF VIROLOGY

Viral Aggregation: Impact on Virus Behavior in the Environment

(2017) Charles P. Gerba et al.   ENVIRONMENTAL SCIENCE & TECHNOLOGY

Genome characterization of a porcine circovirus type 3 in South China

(2017) H. Shen et al.   Transboundary and Emerging Diseases

The occurrence of porcine circovirus 3 without clinical infection signs in Shandong Province

(2017) S. Zheng et al.   Transboundary and Emerging Diseases

First detection of porcine circovirus type 3 on commercial pig farms in Poland

(2017) T. Stadejek et al.   Transboundary and Emerging Diseases

Full-Genome Sequence of Porcine Circovirus type 3 recovered from serum of sows with stillbirths in Brazil

(2017) C. Tochetto et al.   Transboundary and Emerging Diseases

Generation of E. coli-derived virus-like particles of porcine circovirus type 2 and their use in an indirect IgG enzyme-linked immunosorbent assay

(2016) Yan Zhang et al.   ARCHIVES OF VIROLOGY

Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli

(2016) Pei-Ching Wu et al.   JOURNAL OF BIOTECHNOLOGY

A Novel Porcine Circovirus Distantly Related to Known Circoviruses Is Associated with Porcine Dermatitis and Nephropathy Syndrome and Reproductive Failure

(2016) Rachel Palinski et al.   JOURNAL OF VIROLOGY

Yeast as an expression system for producing virus-like particles: what factors do we need to consider?

(2016) H.J. Kim et al.   LETTERS IN APPLIED MICROBIOLOGY

Structural insights into the assembly and regulation of distinct viral capsid complexes

(2016) Subir Sarker et al.   Nature Communications

Next generation vaccines and vectors: Designing downstream processes for recombinant protein-based virus-like particles

(2015) Christopher Ladd Effio et al.   Biotechnology Journal

Aggregation and antigenicity of virus like particle in salt solution—A case study with hepatitis B surface antigen

(2015) Yi Chen et al.   VACCINE

Next generation vaccines and vectors: Designing downstream processes for recombinant protein-based virus-like particles

(2015) Christopher Ladd Effio et al.   Biotechnology Journal

Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies

(2014) Juozas Nainys et al.   BMC BIOTECHNOLOGY

Insect cells as a production platform of complex virus-like particles

(2013) Fabiana Fernandes et al.   Expert Review of Vaccines

Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development

(2012) Pei-Ching Wu et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Impact of Virus Aggregation on Inactivation by Peracetic Acid and Implications for Other Disinfectants

(2011) Michael J. Mattle et al.   ENVIRONMENTAL SCIENCE & TECHNOLOGY

Virus-like particles: innate immune stimulators

(2011) Ramadevi Raghunandan   Expert Review of Vaccines

Efficacy and future prospects of commercially available and experimental vaccines against porcine circovirus type 2 (PCV2)

(2011) Nathan M. Beach et al.   VIRUS RESEARCH

Effect of porcine circovirus type 2 (PCV2) infection on reproduction: disease, vertical transmission, diagnostics and vaccination

(2011) D. M. Madson et al.   ANIMAL HEALTH RESEARCH REVIEWS

A heat-stable hepatitis B vaccine formulation

(2010) Jan Jezek et al.   Human vaccines & immunotherapeutics

The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts

(2009) Sergio A. Bucarey et al.   VACCINE

Efficient production of type 2 porcine circovirus-like particles by a recombinant baculovirus

(2008) Lan-Jun Liu et al.   ARCHIVES OF VIROLOGY

Self-Assembly of the Recombinant Capsid Protein of a Swine Norovirus into Virus-Like Particles and Evaluation of Monoclonal Antibodies Cross-Reactive with a Human Strain from Genogroup II

(2008) H. Almanza et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Physical Stabilization of Norwalk Virus‐Like Particles**The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation.

(2008) Julian Kissmann et al.   JOURNAL OF PHARMACEUTICAL SCIENCES